Medtronic MIRRO MRI Implantable Defibrillator Recall for Potential Therapy Failure Risk
Medtronic's MIRRO MRI implantable cardioverter defibrillators with a specific glassed feedthrough may rarely fail to deliver adequate energy output during high-voltage therapy, affecting approximately 2,831 units distributed worldwide.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA has classified this as a Class I recall, which falls under the Critical category per the severity rubric. A malfunction in energy delivery for an implantable cardiac defibrillator represents a serious risk that could prevent life-saving therapy in dependent patients.
Plain-English summary
Medtronic Inc. is recalling the ICD-DR DDME3D1 MIRRO MRI implantable cardioverter defibrillators (ICDs) and certain cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific glassed feedthrough. Approximately 2,831 units have been distributed nationwide and worldwide. These devices are identified by GTIN 00763000001568 and a large number of specific lot serial numbers (CWS600097S through CWS603267S).
There is a rare potential for reduced or no-energy output during high-voltage therapy, typically 0-12 joules. This defect could compromise the device's ability to deliver appropriate defibrillation therapy during cardiac arrhythmia events when such therapy is critical.
Patients with affected devices should contact their cardiologist or Medtronic immediately to determine whether their specific device is included in this recall. Healthcare providers should review implant records and patient identifiers to identify affected devices. Patients should not discontinue device use without medical guidance and should consult their healthcare provider for assessment and discussion of management or replacement options.
The recalled product
- Product
- ICD-DR DDME3D1 MIRRO MRI, Model Number DDME3D1; Implantable Cardioverter Defibrillators
- Affected units
- 2,831
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- GTIN 00763000001568
- Lot Serial Numbers: CWS603181S
- CWS601328S
- CWS601620S
- CWS601980S
- CWS602302S
- CWS602482S
- CWS602880S
- CWS602742S
- CWS602559S
- CWS602607S
- CWS602433S
- CWS602957S
- CWS601056S
- CWS601348S
- CWS601807S
- CWS602219S
- CWS602422S
- CWS602474S
- CWS601519S
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 120 recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 120 products in this recall →Related recalls
Same manufacturer · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
See all →- CriticalMedtronic CRT-D Defibrillators: Rare Energy Output Failure Risk During Therapy
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillators Recalled for Reduced Therapy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Defibrillators Recalled for Potential Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators at Risk of Reduced Energy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillator may lose energy output during therapy
FDA (Devices) · 2023-06-28
Same hazard · therapy failure
See all →- HighImplantable Vagus Nerve Stimulation Device May Stop Delivering Therapy
FDA (Devices) · 2025-02-05
- HighV.A.C. Ulta Therapy Units Recalled Due to Occlusion Sensor Failures
FDA (Devices) · 2024-12-04
- HighReplacement Lead Wires Recalled for Risk of Treatment Delivery Failure
FDA (Devices) · 2024-05-01
- HighOPTIMIZER CCM X11 Implantable Pulse Generator May Fail to Deliver Therapy
FDA (Devices) · 2024-02-28
- SeverePercussionaire Distal Phasitron respiratory device with reservoir bag assembly defect recalled
FDA (Devices) · 2024-01-24